Proktit
Özet
Bu kapsamlı tıbbi metin, rektal mukozanın iltihaplanması olarak tanımlanan proktit hastalığını; nedenleri, klinik bulguları, tanı yöntemleri ve tedavi yaklaşımları açısından detaylı bir şekilde ele almaktadır. Proktit, enfeksiyöz ve non-enfeksiyöz olmak üzere iki ana gruba ayrılır; enfeksiyöz nedenler arasında özellikle erkeklerle seks yapan erkeklerde riskin arttığı, Neisseria gonorrhoeae, Chlamydia trachomatis ve Herpes simplex gibi cinsel yolla bulaşan patojenler öne çıkar. Tanı sürecinde kültür, nükleik asit amplifikasyon testleri (NAAT) ve fizik muayene kritik rol oynarken; tedavide patojene özgü antibiyotikler ve antiviraller kullanılır. Non-enfeksiyöz nedenler arasında pelvik radyoterapi sonrası gelişen radyasyon proktiti, cerrahi diversiyon sonrası görülen diversiyon proktiti, iskemik proktit ve ülseratif kolitin bir formu olan ülseratif proktit yer alır. Radyasyon proktiti akut veya kronik seyredebilir; tedavisi konservatif yöntemlerden endoskopik müdahalelere ve cerrahiye kadar uzanır. Ülseratif proktit tedavisinde ise topikal mesalamin (5-ASA) ilk seçenek olup, dirençli vakalarda steroidler ve biyolojik ajanlar devreye girer. Metin, her bir alt tür için spesifik risk faktörlerini ve yönetim stratejilerini güncel tıbbi kılavuzlar ışığında sunarak klinisyenlere rehberlik etmektedir.
This comprehensive medical text examines proctitis, defined as the inflammation of the rectal mucosa, in terms of its causes, clinical findings, diagnostic methods, and treatment approaches. Proctitis is classified into infectious and non-infectious causes; among the infectious causes, sexually transmitted pathogens such as Neisseria gonorrhoeae, Chlamydia trachomatis, and Herpes simplex stand out, with an increased risk particularly in men who have sex with men. Culture, nucleic acid amplification tests (NAAT), and physical examination play a critical role in the diagnostic process, while pathogen-specific antibiotics and antivirals are used for treatment. Non-infectious causes include radiation proctitis developing after pelvic radiotherapy, diversion proctitis occurring after surgical diversion, ischemic proctitis, and ulcerative proctitis, which is a form of ulcerative colitis. Radiation proctitis can follow an acute or chronic course, and its treatment ranges from conservative methods to endoscopic interventions and surgery. In the treatment of ulcerative proctitis, topical mesalamine (5-ASA) is the first choice, while steroids and biological agents are utilized in resistant cases. The text provides guidance to clinicians by presenting specific risk factors and management strategies for each subtype in light of current medical guidelines.
Referanslar
Kent A, Keshav S. Managing intractable proctitis and the problematic pouch. Dig Dis. 2014;32(4):427-37.
Centers for Disease Control and PreventionSexually Transmitte Disease Surveillance 2012. Atlanta: U.S. Department of Health and Human Services; 2013
Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59(RR-12):1–110.
Centers for Disease Control and Prevention (CDC). Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007;56(14):332–336.
Maron D. Sexually Transmitted Diseases. American Society of Colon and Rectal Surgeons; 2011 Core Subjects.
Voth ML, Akbari RP. Sexually transmitted proctitides. Clin Colon Rectal Surg 2007;20(1):58–63.
Najib H. Pathology and pathogenesis of radiation bowel disease: Histopathological appraisal in the clinical setting.EMJ Gastroenterol 2018;7:113‑9.
Do NL, Nagle D, Poylin VY. Radiation proctitis: Currentmstrategies in management. Gastroenterol Res Pract 2011;2011:917941.
Terasawa T, Dvorak T, Ip S et al. Systematic review: Charged‑particle radiation therapy for cancer. Ann Intern Med 2009;151:556‑65.
Rhodri S, John TG. Radiation‑induced small bowel disease: Latest developments and clinical guidance. Ther Adv Chronic Dis 2014;5:15‑29.
Zelefsky MJ, Levin EJ, Hunt M et al. Incidence of late rectal and urinary toxicities after three‑dimensional conformal radiotherapy and intensity‑modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124‑9.
Weiner JP, Wong AT, Schwartz D et al. Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding. World J Gastroenterol. 2016 Aug 21;22(31):6972-86.
Klausner JD, Kohn R, Kent C. Etiology of clinical proctitis among men who have sex with men.Clin Infect Dis 2004;38:300–302.
Tabaja L, Sidani SM. Management of radiation proctitis. Dig Dis Sci 2018;63:2180‑8.
Nelamangala Ramakrishnaiah VP, Krishnamachari S. Chronic haemorrhagic radiation proctitis: a review. World J Gastrointest Surg. 2016;8:483–491.
de Vries HJ, Zingoni A, White JA, Ross JD, Kreuter A. 2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens. Int J STD AIDS. 2014 Jun;25(7):465-74.
Wu XR, Liu XL, Katz S et al. Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis. Inflamm Bowel Dis. 2015 Mar;21(3):703-15.
Ko CW, Singh S, Feuerstein JD et al. American Gastroenterological Association Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology. 2019 Feb;156(3):748-764.
Davis TW, Goldstone SE. Sexually transmitted infections as a cause of proctitis in men who have sex with men. Dis Colon Rectum 2009;52(3):507–512.
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2016. Atlanta, GA: US Department of Health and Human Services; 2017.
Satterwhite CL, Torrone E, Meites E et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013;40(3):187-93.
Lamb C, Lamb EI, Mansfield JC et al. Sexually transmitted infections manifesting as proctitis. Front Gastroenterol. 2013; 4(1):32–40.
Workowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015; 64:1-137.
Cone MM, Whitlow CB. “Sexually transmitted and anorectal infectious diseases,” Gastroenterol Clin North Am. 2013;42(4):877-92.
Newman L, Rowley J, Vander Hoorn S et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304.
Silva M, Peixoto A, Albuquerque A et al. Clinical features and outcome of acute ischemic proctocolitis. Gastroenterol Hepatol. 2017;40(1):28-31.
Bowen JM, Gibson RJ, Coller JK et al. Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of agents for the management of cancer treatmentrelated gastrointestinal mucositis and clinical practice guidelines. Support Care Cancer. 2019 Oct;27(10):4011-4022.
Rubin DT, Ananthakrishnan AN, Siegel CA et al. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019 Mar;114(3):384-413.
Kato S, Ishibashi A, Kani K et al. (2018) Optimized management of ulcerative proctitis: When and how to use mesalazine suppository. Digestion 97(1): 59–63.
Durazzo M, Campion D, Fagoonee S et al. Gastrointestinal tract disorders in the elderly. Minerva Med. 2017 Dec;108(6):575-591.
Harbord M, Eliakim R, Bettenworth D et al. Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation (ECCO): Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis 2017; 11: 769–784.
Sonnenberg E, Siegmund B: Ulcerative colitis. Digestion 2016; 94: 181–185.
